PREGNANCY: Pramipexole has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, pramipexole should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Pramipexole is classified as FDA pregnancy risk category C.
NURSING MOTHERS: It is not known if pramipexole is excreted in breast milk. Due to the lack of conclusive safety data, pramipexole should be used cautiously in females who are breastfeeding.
REFERENCE: FDA Prescribing Information.
Quick GuideRestless Legs Syndrome: Home Remedies for RLS and Better Sleep
Report Problems to the Food and Drug Administration
Need help identifying pills and medications?
Use the pill identifier tool on RxList.